Bull Case
ASUR ended 2025 with visible operating momentum: Q4 revenue rose 28% year over year to $39.3M, recurring revenue rose 18%, and adjusted EBITDA reached $11.4M, while management guided to another step-up in 2026 revenue [#8-K-2026-02-26]. If attach-rate gains from Asure Central persist, the stock has room to rerate from a small-cap monitoring valuation.
Bear Case
Forward visibility is still limited. The evidence set is mostly filing-driven, there is no strong recent multi-source demand tape, and the 10-K still flags collection risk around legacy ERTC-related receivables while leverage increased after the MidCap facility and 2025 acquisitions [#10-K-2026-02-26]. If Q1 fails to confirm the Q4 acceleration, the recent margin and growth story could unwind quickly.